SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

CSTL Outperforms MIA

CSTL's DecisionDx-Melanoma's i31-SLNB outperforms MIA Nomogram in identifying patients who may safely forgo sentinel lymph node biopsy

CSTL

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.